Drug class
Gadolinium-based paramagnetic magnetic-resonance imaging (MRI) contrast agent
Mechanism of action
A gadolinium chelate that develops a magnetic moment in a magnetic field and shortens the T1 and, to a lesser extent, T2 relaxation times of nearby water protons, increasing MRI signal intensity.
General use cases
- Contrast enhancement in MRI of the central nervous system and selected liver imaging applications, according to the product label and jurisdiction.
The active imaging entity is the intact gadolinium–gadobenate chelate, not free gadolinium or meglumine. This is a coordination complex/radiology contrast agent; do not merge with other gadolinium chelates.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
